Ituran Location and Control Ltd. ITRN

Ituran Location and Control Ltd. (NASDAQ: ITRN) — deep-value analysis, resumed in REFRESH regime

September 15, 2026 · reference price … (Monday 09/14/2026 close, yfinance) · market cap … on 19.78 mil. shares outstanding · reporting and trading currency: USD

Regime: REFRESH on the reference thesis of 08/23/2026 (rapoarte/deep/2026-08-23-deep-ITRN.md, verdict at the time: WATCH). The mechanical triage deep_delta.py of 09/13/2026 called for resumption for two reasons: an unclassifiable 6-K filing (09/09/2026) and a falsifier that remained unverifiable (revenue_growth_yoy, missing a quarter).

What I explicitly inherit, since no fact touching it has changed: the business and moat structure, the 2019–H1 2026 capital-allocation history, the 06/30/2025 → 06/30/2026 balance-sheet table, the entire O'Glove analysis across five tests (receivables/DSO, inventory/DIO, debt, discretionary expenses, Sloan accruals), the Thorndike grid, the FCF bridge, and the five valuation models as intrinsic values. Between 08/23/2026 and today no new quarter has appeared — the next report (Q3 2026) is scheduled for 11/11/2026 — so all financial figures remain those from the 6-K of 08/12/2026 and the FY2025 20-F.

What I re-derived in this resumption:

1. The new filing (6-K of 09/09/2026, the first multi-year contract for the Big Data platform) — sized and framed; it doesn't move the DCF.
2. The broken falsifier — resolved, with the missing quarter derived from the filing, not guessed.
3. The organic growth / currency translation decomposition, done from scratch with quarterly average market exchange rates (ILS, BRL, MXN, ARS) and the exact geographic weights from the FY2025 20-F. This had been listed in the delta package as "remained unverified, only publishes in the April 2027 20-F." It can be verified today, and the result changes a central figure of the reference thesis: organic growth isn't ~11%, it's ~6%.
4. Subscriber dynamics by channel and country, with average revenue per subscriber in local currency — the first independent confirmation of the "volume, not price" mechanism.
5. The state of the F-3ASR shelf at three and a half months since filing.
6. The MOS of all models, recalculated at today's price; Monte Carlo rerun on the same assumptions.

Primary sources: FY2025 20-F (filed 04/23/2026, CIK 1337117), 6-K of 08/12/2026 (Q2 2026), 6-K of 09/09/2026 (+ Exhibit 99.1), F-3ASR of 05/28/2026, the complete 2026 EDGAR filing list (checked today), data-pack-ITRN-20260915.md, average exchange rates from daily market series.

---

Executive summary

The thesis remains that of August, but with one leg stronger and one leg weaker.

The business is unchanged and continues to be nearly ideal: 2,711,000 subscribers at June 30, 2026, 76% recurring revenue, gross margin …% and operating margin 22.7% in Q2 2026, ROE ~29…, zero financial debt, and … cash. Tangible capital employed is under … for ~… of after-tax operating profit — a return on tangible capital on the order of 90…. Nothing in the last three weeks' filings touches this picture.

The stronger leg: I could finally measure how much of the growth is currency. The reference thesis estimated 8-9 points of translation out of the 19.7 points of H1 2026 growth, hence organic growth "on the order of 11%." With the exact weights from the 20-F (Israel 54.8% of revenue, Brazil 22.9%, the rest 22.3%) and the real quarterly average rates (the shekel 3.5951 → 3.0366 versus the dollar between H1 2025 and H1 2026, i.e. … translation effect; the real …), the overall currency effect is +12.6 to +12.8 percentage points, not 8-9. H1 2026 organic growth is …, and Q2 2026 is +5.6…5.7%. Independent confirmation comes from subscribers: the base grew from 2,548,000 to 2,711,000 over four quarters, i.e. …. The two figures, obtained via completely separate paths, coincide. The g1 = 6% assumption in the DCF is no longer a prudent estimate — it's the measured organic rate.

The weaker leg: the volume pace is decelerating. In 2025, the subscriber base grew 9.2% (2,409,000 → 2,630,000, 221,000 net additions). Over the trailing four quarters it grew 6.4% (163,000 net additions), and Q2 2026 brought 41,000 — an annualized pace of 164,000. Product revenue, the physical channel through which new subscribers enter, grew 8% YoY in Q2 in dollars, but with a translation effect of ~+14 points on its geographic mix, that means a decline of ~5% in local currency. The company's only real engine — volume — is slowing exactly in the quarters where dollar reporting shows records.

The new filing (09/09/2026) is a small good-news item, not a thesis change. Ituran won its first multi-year commercial contract for the Big Data platform: a SaaS traffic-monitoring service for entities of the Israeli Ministry of Transport, for up to four years, total value over NIS 21 mil. (~…), of which only NIS 5 mil. (~…) in the first year is guaranteed. Against annualized revenue of ~…, that's 0.4% of revenue. Even at a generous incremental margin of 80… on already-collected data, the contribution to operating profit is ~…, i.e. ~1.6% of estimated 2026 operating profit, or ~1.5% of the price capitalized at 10x. I'm not raising g1 for it and not putting it in the DCF. Its value is of another nature: it's the first external proof that the data platform can be sold separately from subscriptions, after management had announced it in February as one of three growth initiatives (Big Data, IturanMob — shared-mobility rental, launched in the US, and monetizing carbon credits for electric-vehicle drivers).

Estimated value. The flow to the shareholder used in the valuation remains … — normalized FCFE, defined in the valuation chapter and untouched by the new filings. The five triangulated models, recalculated at … give a range from … (pessimistic DCF) to … (optimistic DCF), with the median at …. Monte Carlo over 20,000 scenarios (same assumptions: OE 65, g1 6%, r 10%, gt 2%, net cash −95) gives a median intrinsic value of … and a median MOS of ** …**, with … probability of undervaluation — but P25 is …, i.e. a quarter of scenarios are more than ten percent worse than the price paid.

Verdict: WATCH — unchanged, but with a sounder justification than in August. In August I said "expensive on three of five models, and the family has its whole package on the shelf." Today I add something heavier: the business's real growth rate is 6%, not 20%, and it's decelerating, while the price bakes in …x profit and a re-rating from the historical median of 10.5x. The entry threshold remains …-40 (the EPV Greenwald zone). Anyone already holding the stock has no reason for an urgent sale: the regular 3.92% dividend pays for the wait, the balance sheet is debt-free, and the business isn't breaking — it's gotten expensive.

---